Fennec Pharmaceuticals FENC
NASDAQ FENC
$12.39 -0.16 (-1.28%)
As of: Sep 4, 2026 · 3:59 PM EDT

Fennec Pharmaceuticals (FENC) Capital Expenditures (2024)

Fennec Pharmaceuticals' (FENC) quarterly Capital Expenditures came in at $1.7 million in Q1 2024.

Analysis

Fennec Pharmaceuticals (FENC) Capital Expenditures (2024) Analysis & Trends

Fennec Pharmaceuticals (FENC) has 1 years of Capital Expenditures data on file, last reported at $1.7 million in Q1 2024.

  • Quarterly Capital Expenditures changed N/A year-over-year to $1.7 million in Q1 2024, while the trailing twelve-month figure through Jun 2024 was $1.7 million (changed N/A YoY) and the FY2025 annual result came in at $2.8 million, changed N/A from the prior year.
  • Capital Expenditures was little changed at $1.7 million in Q1 2024.
  • In the past five years, Capital Expenditures ranged from a high of $1.7 million in Q1 2024 to a low of $1.7 million in Q1 2024.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Capital Expenditures (Qtr)
1 Vertex Pharmaceuticals 138.47 Bn 130.62 Bn 2.84 Bn 112.20 Mn
2 Regeneron Pharmaceuticals 85.18 Bn 77.19 Bn 3.93 Bn 240.20 Mn
3 Argenx Se 63.38 Bn 58.19 Bn 1.37 Bn -
4 Moderna 58.09 Bn 52.95 Bn 52.00 Mn 37.00 Mn
5 Revolution Medicines 44.33 Bn 44.33 Bn - 2.29 Mn
6 BeOne Medicines 40.02 Bn 34.92 Bn 1.53 Bn 25.02 Mn
7 Alnylam Pharmaceuticals 35.57 Bn 32.27 Bn 992.69 Mn 34.68 Mn
8 Royalty Pharma 28.45 Bn 27.61 Bn - 251.02 Mn
9 Insmed 27.48 Bn 26.32 Bn 358.27 Mn 6.26 Mn
10 Fennec Pharmaceuticals 432.85 Mn 391.60 Mn 17.15 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2024 1.74 Mn